宋春丽,任吉华,张祯祯,等.SIRT1基因沉默诱导肝癌细胞老化及其机制[J].第三军医大学学报,2012,34(19):1929. Song Chunli,Ren Jihua,Zhang Zhenzhen,et al.Silent information regulator 1 gene induces aging of hepatocellular carcinoma cells via p53/p21 pathway[J].J Third Mil Med Univ,2012,34(01):1929. [2]李建国,江小杰.原发性肝癌RUNX3基因启动子区甲基化及其意义[J].第三军医大学学报,2012,34(19):1933. Li Jianguo,Jiang Xiaojie.Methylation of RUNX3 gene promoter in HCC and its significance[J].J Third Mil Med Univ,2012,34(01):1933. [3]左国华,梁平,李洪艳.肝细胞癌免疫磁珠的制备及鉴定[J].第三军医大学学报,2005,27(16):1700. [4]张小丽,高建,贾茜,等.肝癌干细胞样细胞的分离及其耐药性受PI3K/Akt通路调节[J].第三军医大学学报,2013,35(02):99. Zhang Xiaoli,Gao Jian,Jia Qian,et al.Isolation of HCC cancer stem-like cells and chemo-resistance mediated by PI3K/Akt pathway[J].J Third Mil Med Univ,2013,35(01):99. [5]于月新,李巨.紫草素逆转绒癌细胞JAR/MTX耐药与survivin和Bcl-2表达关系研究[J].第三军医大学学报,2007,29(19):1880. YU Yue-xin,LI Ju.Relationship between the reverse effect of shikonin on methotrexate-resistant human choriocarcinoma cell line JAR/MTX and expressions of survivin and Bcl-2[J].J Third Mil Med Univ,2007,29(01):1880. [6]杨兆瑞,吴晴,陈嘉薇,等.HIF-1α、JNK1、P-gp、MRP1和LRP蛋白在胃癌中的表达与临床病理及预后的关系[J].第三军医大学学报,2007,29(18):1755. YANG Zhao-rui,WU Qing,CHEN Jia-wei,et al.Expressions, clinicopathological features and prognostic significance of HIF-1α, JNK1, P-gp, MRP1 and LRP proteins in human gastric carcinoma[J].J Third Mil Med Univ,2007,29(01):1755. [7]谢斌,唐春,吴刚,等.c-Met、MMP-2、MMP-9在肝细胞癌中的表达及临床意义[J].第三军医大学学报,2008,30(12):1140. XIE Bin,TANG Chun,WU Gang,et al.Expressions and clinical significances of c-Met, MMP-2, MMP-9 in metastasis of human hepatocellular carcinoma: report of 47 cases[J].J Third Mil Med Univ,2008,30(01):1140. [8]廖翠薇,邹利光,卫静,等.实验性肝细胞癌SPIO增强MRI及其病理学对照研究[J].第三军医大学学报,2006,28(01):38. [9]李静,沈宜,杨麟,等.小鼠肝癌细胞(H22)源外泌体的体内抗肝癌作用研究[J].第三军医大学学报,2008,30(19):1836. LI Jing,SHEN Yi,YANG Lin,et al.Antitumor effects of exosomes derived from a mouse hepatoma carcinoma cell line H22[J].J Third Mil Med Univ,2008,30(01):1836. [10]李昆霖,吴国明,戢福云,等.人小细胞肺癌多药耐药细胞差异表达基因的克隆研究[J].第三军医大学学报,2006,28(24):2403.
